Home/Filings/4/0000899243-24-000168
4//SEC Filing

HAMERSLAG STEVEN J 4

Accession 0000899243-24-000168

CIK 0000874866other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 9:51 PM ET

Size

36.4 KB

Accession

0000899243-24-000168

Insider Transaction Report

Form 4
Period: 2024-02-07
Transactions
  • Sale

    Common Stock

    2024-02-09$239.52/sh1,019$244,071112,443 total(indirect: See Footnote)
  • Sale

    Common Stock

    2024-02-09$240.27/sh255$61,269112,188 total(indirect: See Footnote)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-02-071,0000 total
    Exercise: $48.35Exp: 2027-08-03Common Stock (1,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-07$48.35/sh+1,000$48,3501,000 total
  • Exercise/Conversion

    Common Stock

    2024-02-07$87.49/sh+3,000$262,4707,000 total
  • Gift

    Common Stock

    2024-02-074,9210 total
  • Sale

    Common Stock

    2024-02-08$239.67/sh1,192$285,687115,197 total(indirect: See Footnote)
  • Sale

    Common Stock

    2024-02-09$238.21/sh927$220,821113,462 total(indirect: See Footnote)
  • Sale

    Common Stock

    2024-02-09$241.42/sh430$103,811111,758 total(indirect: See Footnote)
  • Sale

    Common Stock

    2024-02-09$242.32/sh290$70,273111,468 total(indirect: See Footnote)
  • Gift

    Common Stock

    2024-02-07+4,921116,389 total(indirect: See Footnote)
  • Exercise/Conversion

    Common Stock

    2024-02-07$57.35/sh+3,000$172,0504,000 total
  • Tax Payment

    Common Stock

    2024-02-07$232.26/sh2,079$482,8694,921 total
  • Sale

    Common Stock

    2024-02-08$240.36/sh808$194,211114,389 total(indirect: See Footnote)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-02-073,0000 total
    Exercise: $87.49Exp: 2029-08-08Common Stock (3,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-02-073,0000 total
    Exercise: $57.35Exp: 2028-08-02Common Stock (3,000 underlying)
Footnotes (13)
  • [F1]Reflects the exercise of stock options awarded to the Reporting Person on August 3, 2017. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date.
  • [F10]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $239.01 to $239.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F11]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $240.01 to $240.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F12]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $241.03 to $241.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F13]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $242.05 to $242.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Reflects the exercise of stock options awarded to the Reporting Person on August 2, 2018. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date.
  • [F3]Reflects the exercise of stock options awarded to the Reporting Person on August 8, 2019. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date.
  • [F4]Reflects shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), withheld by the Issuer to cover the Reporting Person's exercise price of the stock options reported herein.
  • [F5]On February 7, 2024, the Reporting Person made a bona fide gift of 4,921 shares of Common Stock to the Steven J. Hamerslag and Jean Wells Hamerslag Trust Dtd. 12/09/88 (the "Hamerslag Trust"), of which the Reporting Person is a trustee.
  • [F6]The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust.
  • [F7]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $239.39 to $239.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission (the "Staff"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F8]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $240.01 to $240.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F9]Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $238.00 to $238.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

CORVEL CORP

CIK 0000874866

Entity typeother

Related Parties

1
  • filerCIK 0001056168

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:51 PM ET
Size
36.4 KB